Functional recovery in new mouse models of ALS/FTLD after clearance of TDP-43 pathology

被引：0
|
作者：
Walker, A. [1 ]
Spiller, K. [1 ]
Ge, G. [1 ]
Zheng, A. [1 ]
Xu, Y. [1 ]
Zhou, M. [1 ]
Tripathy, K. [1 ]
Kwong, L. [1 ]
Trojanowski, J. [1 ]
Lee, V. [1 ]
机构：
[1] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA
来源：
JOURNAL OF NEUROCHEMISTRY | 2015年 / 134卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
MTU11-44
引用
收藏
页码：208 / 209
页数：2
相关论文
共 50 条
  • [1] Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
    Adam K. Walker
    Krista J. Spiller
    Guanghui Ge
    Allen Zheng
    Yan Xu
    Melissa Zhou
    Kalyan Tripathy
    Linda K. Kwong
    John Q. Trojanowski
    Virginia M.-Y. Lee
    Acta Neuropathologica, 2015, 130 : 643 - 660
  • [2] Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43
    Walker, Adam K.
    Spiller, Krista J.
    Ge, Guanghui
    Zheng, Allen
    Xu, Yan
    Zhou, Melissa
    Tripathy, Kalyan
    Kwong, Linda K.
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    ACTA NEUROPATHOLOGICA, 2015, 130 (05) : 643 - 660
  • [3] Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
    Wood, Alistair
    Gurfinkel, Yuval
    Polain, Nicole
    Lamont, Wesley
    Lyn Rea, Sarah
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [4] The role of TDP-43 in the pathogenesis of ALS and FTLD
    Baralle, Marco
    Buratti, Emanuele
    Baralle, Francisco E.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2013, 41 : 1536 - 1540
  • [5] Ubiquitinated TDP-43 is associated with FTLD and ALS
    Nature Clinical Practice Neurology, 2007, 3 (1): : 7 - 8
  • [6] Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD
    Yamashita, Takenari
    Teramoto, Sayaka
    Kwak, Shin
    NEUROSCIENCE RESEARCH, 2016, 107 : 63 - 69
  • [7] Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy
    Arai, Tetsuaki
    Hasegawa, Masato
    Nonoka, Takashi
    Kametani, Fuyuki
    Yamashita, Makiko
    Hosokawa, Masato
    Niizato, Kazuhiro
    Tsuchiya, Kuniaki
    Kobayashi, Zen
    Ikeda, Kenji
    Yoshida, Mari
    Onaya, Mitsumoto
    Fujishiro, Hiroshige
    Akiyama, Haruhiko
    NEUROPATHOLOGY, 2010, 30 (02) : 170 - 181
  • [8] TDP-43 pathology in FTLD-subtypes
    Nishihira, Yasushi
    Mao, Qinwen
    Kohler, Missia
    Coppola, Giovanni
    Rademakers, Rosa
    Rademaker, Alfred
    Weintraub, Sandra
    Mesula, M-Marsel
    Geula, Changiz
    Bigio, Eileen H.
    BRAIN PATHOLOGY, 2019, 29 : 80 - 80
  • [9] ALS and FTLD: two faces of TDP-43 proteinopathy
    Liscic, R. M.
    Grinberg, L. T.
    Zidar, J.
    Gitcho, M. A.
    Cairns, N. J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (08) : 772 - 780
  • [10] Evidence from human studies for spreading/staging of TDP-43 pathology in FTLD and ALS
    Halliday, G.
    Tan, R.
    Fatima, M.
    Hodges, J.
    Kiernan, M.
    Kril, J.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 235 - 235
12345